Alison - Interview 14  

Alison - Interview 14

Age at Interview: 39
Sex: Female
Background: Alison, aged 39 years is White British, works part time as a music teacher and lives with her husband and three children. Her son was diagnosed with Intrauterine Growth Restriction around 22 weeks. Alison gave birth to her son at 30 weeks; he weighed 2lbs.

Brief outline:Alison talks about her experiences of three different clinical trials since the birth of her son. Two whilst in the neonatal unit of which one she was not eligible. The third trial involved her son receiving Growth Hormone Treatment.

More about me...

To watch or read an interview clip, click on the heading that interests you. Either a video,audio recording or text will open, depending on the clip
To read what was said without video or audio, click here
To print the interview’s text, click here
The trial was unable to show any beneficial effect. This is still an important finding for the prevention and treatment of sepsis in premature babies and for future research.
 
The trial was unable to detect any beneficial effect. This is still an important finding for the prevention and treatment of sepsis in premature babies and for future research.
 
Alison’s son took part in a trial on the best dosage for growth hormone in children.
 
People like to read and digest information in different ways. Alison felt on one occasion she would have liked more time in advance to read the information and ask questions.
 
In a crisis, it can be difficult to read and understand all the various terms used to explain a trial and so Alison had a few questions to ask before giving consent. She adds that parental involvement in helping to draft information leaflets is a valuable way to reflect people’s needs.
 
When there isn’t anything medically wrong with your child it can be a hard decision to make.
 
Alison felt more willing to enrol her son in trials because of the excellent care received, but being approached at a vulnerable time is difficult.
 
How health professionals approach parents and how they communicate is essential when asking them to consent to their child taking part in a clinical trial.
 
Sharing the decision with her husband was essential to Alison, particularly when it is your child you are putting forward for a trial.
 
Now that Alison’s son is older an able to communicate his feelings about taking part in trials, she respects his decision to stop taking part.
 
Sometimes wanting the best for your children can appear a little selfish, but as a parent when an opportunity arises you consider taking it.
 
Taking part in a trial can mean you may be more closely monitored; but if you’re not in a trial you will still get the best standard care.
 
Alison felt more willing to take part in trials because of the excellent care received.
 
Alison’s preterm baby was not eligible to take part in a trial comparing different ventilators because he could breathe without help when born.
 
When you enrol your child in a randomised trial, you have to be prepared to accept whichever treatment you will be given.
 
Taking part in the trial was made easy for Alison when she was on the neonatal ward and for the follow-up hospital appointments, so it had a very low impact on her and her family.
 
Alison had to weigh up the demands of the trial with the demands of family life and work and decided it was time to stop the trial.
 
Alison felt that offering a payment may change people’s attitude to taking part in trials, but if it is a long term commitment and involves ongoing treatment then maybe a payment is right.
 
Alison was pleased that expenses were always paid quickly. However, taking part in a trial does require parents and children to give their time and this is harder to compensate.
 
Alison kept the personal feedback from the tests her son had taken during a growth hormone trial for when he is older; it’s part of his history and identity.
 
Stopping involvement in the trial meant fewer hospital appointments and fewer tests on her son, which was a relief. However, Alison and her son have no regrets about taking part, knowing that they have helped other children.
 
The research team took great care to explain the results clearly and simply that made them easy to read and understand.
 
The communication and feedback was brilliant, although it was a little disappointing that the results did not show any benefit for a new antibiotic for pre-term babies.
 
Sometimes the demands of a clinical trial and the child’s discomfort are reasons for withdrawing. Alison felt a bit apologetic to the research team that her son had left the trial, but they were fine about it.
 
Alison says it was quite a relief once she had made the decision to withdraw. It felt like the right decision for the family and time for her son to move on.
 
Parents place a lot of trust in the health professionals caring for their children, and this may be important when making a decision about enrolling your child.
 
A good use of resources might be to target information at people who would not normally volunteer for trials and ensure they have an opportunity to take part.
 
When you get the results of a trial, it gives you a sense of being part of a wider community rather than just a number.
 
Parent involvement in helping to write information leaflets is a valuable way to reflect parent’s and young people’s needs.
 
It’s really down to the individual being open to support research and helping other children, but also respecting that you can say no.
 
Alison’s son took part in a trial that showed no beneficial effects; she feels that parents should be informed at the start of a trial that this finding is always possible.
Jon Snow introduces Healthtalkonline
   Support our work

Mail to a friend

Send